Neuronetics Declares Up to date Medicare Coverage Increasing Entry to NeuroStar TMS Remedy by means of Nurse Practitioners

Neuronetics Declares Up to date Medicare Coverage Increasing Entry to NeuroStar TMS Remedy by means of Nurse Practitioners

NGS MAC Permits Non-Doctor Practitioners with Autonomy to Prescribe TMS

MALVERN, Pa., Feb. 10, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a business stage medical expertise firm centered on designing, growing, and advertising and marketing merchandise that enhance the standard of life for sufferers who are suffering from neurohealth issues, immediately introduced a healthcare coverage replace from Nationwide Authorities Providers, Inc. (NGS) that will increase entry for sufferers to its NeuroStar® Superior Remedy for Psychological Well being transcranial magnetic stimulation (TMS). The NGS coverage, efficient April 1, 2023, will enable non-physician practitioners (NPPs) who’re inside their scope of observe to order and supply TMS therapy to their sufferers with main depressive dysfunction (MDD).

“We acknowledge and recognize the numerous function of psychiatric nurse practitioners in delivering psychological healthcare and are already centered on making NeuroStar accessible in NPP practices,” stated Keith J. Sullivan, President and CEO of Neuronetics Inc. “Our well being coverage staff is dedicated to partnering with our suppliers and payers to broaden coverage protection and permit extra sufferers to have entry to doubtlessly life-saving remedies like NeuroStar TMS.”

NGS is the Medicare Administrative Contractor for six.3 million lined lives in MN, WI, IL, NY, NH, VT, ME, MA, RI, and CT. An extra replace within the revised NGS coverage is a decrease treatment requirement – ​​diminished from 4 failed drugs to 2 previous to TMS therapy.

“Particularly now, with a nationwide psychological well being disaster and a scarcity of psychological healthcare suppliers, psychiatric nurse practitioners are sometimes a affected person’s go-to supplier for analysis and therapy,” stated Akos Antwi, Psychiatric Psychological Well being Nurse Practitioner at Revive Therapeutic Providers. “Empowering NPs with the instruments they require, like NeuroStar TMS, can solely enhance the extent of look after these sufferers who need assistance.”

Main depressive dysfunction (MDD) is a critical problem that impacts 21 million adults in the USA, with 6.4 million folks being underserved by antidepressant treatment. NeuroStar TMS is a non-drug therapy that may assist alleviate the burden of drug-resistant despair.

Neuronetics is the one TMS firm within the business with a devoted well being coverage staff that companions with each suppliers and payers to advocate for well being coverage modifications. NGS has applied this coverage change after contemplating public feedback made by Neuronetics, NeuroStar suppliers, and others. Neuronetics has beforehand introduced favorable TMS protection updates in October 2022 and July 2022.

For extra details about NeuroStar TMS Remedy, please go to

About Neuronetics
Neuronetics, Inc. consider that psychological well being is as necessary as bodily well being. As a worldwide chief in neuroscience, Neuronetics is redefining affected person and doctor expectations with its NeuroStar Superior Remedy for Psychological Well being. NeuroStar is a non-drug, noninvasive therapy that may enhance the standard of life for folks affected by neurohealth circumstances when conventional treatment hasn’t helped. NeuroStar is FDA-cleared for adults with main depressive dysfunction (MDD), as an adjunct for adults with obsessive-compulsive dysfunction (OCD), and to lower anxiousness signs in grownup sufferers with MDD which will exhibit comorbid anxiousness signs (anxious despair). NeuroStar Superior Remedy is the main transcranial magnetic stimulation (TMS) therapy for MDD in adults with over 5 million remedies delivered. NeuroStar is backed by the most important scientific knowledge set of any TMS system for despair, together with the world’s largest despair Outcomes Registry. Neuronetics is dedicated to remodeling lives by providing an distinctive therapy that produces extraordinary outcomes. For security and prescribing data,

Media Contact:
[email protected]